Wellgistics Health, a leader in pharmaceutical distribution, announced financial results for the second fiscal quarter of 2025.
The company reported revenue of $18.65 million in the first half of 2025, showing stability compared to the previous year.
CEO Brian Norton highlighted the strategic growth initiatives and transformation progress achieved by Wellgistics Health.
Operational Integration
Consolidated operations, reduced SG&A, and upgraded ERP system for improved efficiency.
Governance & Balance Sheet
Appointed top audit network, obtained SOC 2 certification, and converted debt to equity for financial flexibility.
Growth Initiatives
Advanced AI-driven technology, expanded partnerships, and positioned for direct-to-patient leadership in healthcare.
DTP Model Expansion
Scaling manufacturer-to-patient programs in therapeutic areas to enhance access and affordability.
- Wellgistics Health's financial stability and growth initiatives signal a positive trajectory for the company's future.
- The strategic focus on operational efficiency, balance sheet improvements, and technology integration is expected to drive sustainable growth in the pharmaceutical distribution sector.
Wellgistics Health's disciplined approach and focus on innovation position the company for continued success in the evolving healthcare landscape.